Dioxaphetyl butyrate
From Wikipedia, the free encyclopedia
(Redirected from Dioxaphetyl Butyrate)
 |
|
| Clinical data | |
|---|---|
| Routes of administration |
Oral, Other ROA Unknown |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
|
|
| Synonyms | Amidalgon, Spasmoxal |
| CAS Number | 467-86-7  |
| PubChem (CID) | 48194 |
| ChemSpider | 43838  |
| UNII | G751H98FY4 |
| ECHA InfoCard | 100.006.731 |
| Chemical and physical data | |
| Formula | C22H27NO3 |
| Molar mass | 353.45 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Dioxaphetyl butyrate (INN; trade names Amidalgon, Spasmoxal) is an opioid analgesic which is a diphenylacetic acid derivative, related to other open-chain opioid drugs such as dextropropoxyphene, levacetylmethadol (LAAM), lefetamine and dimenoxadol.
It produces similar effects to other opioids, including dependence, euphoria, analgesia, sedation, constipation, dizziness and nausea.
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9621 and a 2013 annual aggregrate manufacturing quota of zero.
References[edit]
 |
This article does not cite any sources. (November 2009) (Learn how and when to remove this template message) |
 |
This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
